BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 17,710
+30 (0.17%)
Jul 18, 2025, 3:30 PM KST
BINEX Company Description
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea.
The company engages in cell line and process development, and analytical method production development.
It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products.
BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea.
BINEX Co., Ltd.
| Country | South Korea |
| Founded | 1957 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 616 |
| CEO | Hyuk-Jong Lee |
Contact Details
Address: 368-3, Dadae-ro Busan, 49496 South Korea | |
| Phone | 82 3 2850 3236 |
| Website | bi-nex.co.kr |
Stock Details
| Ticker Symbol | 053030 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7053030003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hyuk-Jong Lee | Chief Executive Officer |